St Jude starts FAME II trial of guided coronary interventions
This article was originally published in Clinica
Executive Summary
St Jude Medical has enrolled the first of 1,600 patients in its FAME II trial. The study aims to evaluate whether its fractional flow reserve (FFR) guidewires aid the treatment of stable coronary artery disease.